Ronghui Yu

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial Fibrillation

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Efficacy and safety of intensive statin therapy in Chinese patients with atherosclerotic intracranial arterial stenosis: A single-center, randomized, single-blind, parallel-group study with one-year follow-up

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Approach to the Catheter Ablation Technique of Paroxysmal and Persistent Atrial Fibrillation: A Meta-Analysis of the Randomized Controlled Trials

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation

Exercise-based cardiac rehabilitation for coronary heart disease

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Modifiable Risk Factors and Atrial Fibrillation

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Exercise-based Cardiac Rehabilitation in Patients With Coronary Heart Disease: meta-analysis Outcomes Revisited

Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation

Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

How to Approach Reentrant Atrial Tachycardia After Atrial Fibrillation Ablation

Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives

Predictors of Very Late Recurrence of Atrial Fibrillation After Circumferential Pulmonary Vein Ablation

Metabolic Syndrome and Risk of Recurrence of Atrial Fibrillation After Catheter Ablation(Arrhythmia/Electrophysiology)

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation

HbA1c levels as predictors of ablation outcome in type 2 diabetes mellitus and paroxysmal atrial fibrillation

Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention (ISCAP study)

The fibrosis and atrial fibrillation: Is the transforming growth factor-β1 a candidate etiology of atrial fibrillation

Achievement of Pulmonary Vein Isolation in Patients Undergoing Circumferential Pulmonary Vein Ablation: A Randomized Comparison Between Two Different Isolation Approaches

Is Circumferential Pulmonary Vein Isolation Preferable to Stepwise Segmental Pulmonary Vein Isolation for Patients With Paroxysmal Atrial Fibrillation? A Randomized Study

Knowledge of secondary prevention guidelines for coronary heart disease: results from a physicians’ survey in China